Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H ( (HK:9989) ) has issued an update.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has announced an update to its final dividend for the year ended December 31, 2024. The company will pay a final ordinary dividend of RMB 2.5 per 10 shares, with the default currency for payment being HKD 2.7165 per 10 shares. The ex-dividend date is set for May 26, 2025, and the payment date is July 22, 2025. The announcement includes details on the withholding tax rates applicable to different categories of shareholders, which are influenced by their residency status and relevant tax agreements with China.
The most recent analyst rating on (HK:9989) stock is a Sell with a HK$3.88 price target. To see the full list of analyst forecasts on Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H stock, see the HK:9989 Stock Forecast page.
More about Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
Average Trading Volume: 2,506,922
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.59B
See more data about 9989 stock on TipRanks’ Stock Analysis page.